Results 121 to 130 of about 653,222 (236)

Psychometric validation of the experience with allergic rhinitis nasal spray questionnaire

, 2011
Bruce Crawford1, Richard H Stanford2, Audrey Y Wong3, Anand A Dalal2, Martha S Bayliss11Mapi Values, Boston, MA, USA; 2GlaxoSmithKline, Research Triangle Park, NC, USA; 3BioMedical Insights, San Francisco, CA, USABackground: Patient experience and ...
Wong AY, Dalal AA, Crawford B, Stanford RH, Bayliss MS   +4 more
core  

Sex‐Specific Differences in Symptomatology and Quality of Life Impact of Allergic Rhinitis: A Cross‐Sectional Study

Immunity, Inflammation and Disease, Volume 14, Issue 10, October 2026.
ABSTRACT Background Allergic Rhinitis (AR) is a widespread condition that significantly affects the quality of life (QOL) of those affected globally. It contributes to sleep disturbances, fatigue, poor concentration, irritability, and can worsen symptoms in individuals with coexisting asthma.
Hasan Ibrahim Al‐Balas, Almu'atasim Khamees, Shatha Khaled Al Saoud, Sajeda Ahmad Aldakhiel, Wasan Abdallah Bani Issma'eel, Farah Nayef Alzu'bi, Nour Ahmad Mistareehi, Majd Mohammed Qashou', Sireen Kamal Ayasrah   +8 more
wiley   +1 more source

Enhanced Early Detection of Allergic Rhinitis: A Prospective Study on a Symptom‐Based Predictive Model

World Journal of Otorhinolaryngology - Head and Neck Surgery, Volume 12, Issue 5, Page 586-597, October 2026.
ABSTRACT Introduction Allergic rhinitis (AR) and non‐allergic rhinitis (NAR) share overlapping symptoms but differ in pathophysiology and treatment. Current AR diagnosis relies on skin prick testing (SPT) and serum IgE quantification, both of which are complex.
Ke‐Zhang Zhu, Chao He, Si‐Zhe Zhu, Zheng Liu, Ming Zeng   +4 more
wiley   +1 more source

Evaluating stapokibart in the treatment of seasonal allergic rhinitis

Immunotherapy
Seasonal allergic rhinitis (SAR) is a chronic inflammatory condition primarily mediated by type 2 immune responses, typically triggered by specific pollens. Stapokibart is a humanized monoclonal antibody anti-interleukin-4 receptor α subunit, thereby blocking IL-4 and IL-13 signaling pathways.
Wang, Menglin, Li, Jingyun, Zhang, Luo, Zhang, Yuan   +3 more
openaire   +3 more sources

Subjective and objective markers of treatment response in patients with seasonal allergic rhinitis

, 2000
Although there is a recognized association between upper and lower allergic airways disease, it is unknown how seasonal allergic rhinitis (SAR) therapy will effect sensitive markers of airway function in patients with no history of ...
Lipworth, Brian J., Sims, Erika J., Wilson, Andrew M., Dempsey, Owen J., Brian J Lipworth, Andrew M Wilson, Owen J Dempsey, Erika J Sims   +7 more
core   +1 more source

Established Tissue Eosinophilia is Not Synonymous With Ongoing Local Type 2 Cytokine Activity

Allergy, EarlyView.
Franziska U. Nordström, Malin Lindstedt, Lennart Greiff, Jonas S. Erjefält   +3 more
wiley   +1 more source

Hay Fever Symptom Burden From Grass Pollen: Implications for Public Health Warning Thresholds

GeoHealth, Volume 10, Issue 10, October 2026.
Abstract This study quantifies the lagged association between grass pollen exposure and the onset of allergic rhinitis (AR) symptoms, including differences between asthmatic and non‐asthmatic subgroups. Data included 114,834 self‐reported AR symptoms collected from 25,194 uniquely identified users of a smartphone application.
Max J. Tyler, Darsy Darssan, Edwin R. Lampugnani, Nicholas J. Osborne   +3 more
wiley   +1 more source

BLOOD LIPID LEVELS RELATED TO ALLERGIC RHINITIS: A SIGNIFICANT ASSOCIATION?

, 2017
Allergic rhinitis is a common problem increasing greatly over the past three decades. Several studies have found a possible link between dyslipidemia and allergic disease but the relating causal mechanisms remain elusive.
Ignazio La Mantia, Claudio Andaloro, Varricchio, A, Attilio Varricchio, ALBANESE, PASQUALE GIANLUCA   +4 more
core   +1 more source

Prevalence and Sociodemographic Variation of Allergic Diseases in Australia: Findings From the Australian National Health Survey

Clinical &Experimental Allergy, Volume 56, Issue 10, Page 1191-1204, October 2026.
Using data from 17,093 participants in the 2022 Australian National Health Survey, this study is the first to report nationwide prevalence estimates for allergic rhinitis (23.9%), food allergy (7.0%), drug allergy (5.2%), eczema (1.6%) and diagnosed asthma (10.8%) across Australia.
Yichao Wang, Jennifer J. Koplin, Janet M. Davies, Constance H. Katelaris, Debra J. Palmer, Jason A. Trubiano, Joy Lee, Michaela Lucas, Michael O′Sullivan, Sandra Vale, Sheryl van Nunen, Troy Wanandy, Dianne E. Campbell, Kirsten P. Perrett, Rachel L. Peters   +14 more
wiley   +1 more source

Rebound Pruritus and Urticaria After Discontinuation of Chronic Antihistamine Use—A Scoping Review

Clinical &Experimental Allergy, Volume 56, Issue 10, Page 1205-1214, October 2026.
Rebound pruritus and urticaria have been reported after discontinuation of chronic cetirizine or levocetirizine use only. Symptoms typically occur within 0.5–5 days after stopping therapy and appear more frequently reported in female patients. Re‐initiation of antihistamines is the most commonly effective management strategy, highlighting the need for ...
Jun Jie Benjamin Seng, Prawira Oka, Ngiap Chuan Tan   +2 more
wiley   +1 more source